GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 16, 2025

Primary Completion Date

January 6, 2026

Study Completion Date

January 6, 2026

Conditions

Influenza

Interventions

BIOLOGICAL

FLUENZ

LAIV (Intranasal Influenza Vaccine)

BIOLOGICAL

Influenza challenge virus

Influenza challenge virus (H3N2 strain)

Trial Locations (1)

RECRUITING

Imperial Clinical Research Facility, Imperial College Healthcare NHS Trust, London

All Listed Sponsors

collaborator

Imperial College Healthcare NHS Trust

OTHER

lead

Imperial College London

OTHER

NCT06620185 - GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE | Biotech Hunter | Biotech Hunter